Quick Answer
Cyclerion Therapeutics, Inc. reported Total Revenue of $2.07 million for fiscal year 2025.
Cyclerion Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $2.07M | +3.7% |
| 2024 | $2.00M | — |
| 2023 | $0.00 | -100.0% |
| 2022 | $297.0K | -92.5% |
| 2021 | $3.94M | +71.7% |
| 2020 | $2.30M | -49.1% |
| 2019 | $4.51M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $875.0K | +351.0% | +840.9% |
| June 30, 2025 | $93.0K | — | +14.8% |
| March 31, 2025 | $81.0K | — | -58.2% |
| September 30, 2024 | $194.0K | — | — |
| June 30, 2024 | $0.00 | — | — |
| March 31, 2024 | $0.00 | — | — |
| September 30, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | -100.0% | — |
- Cyclerion Therapeutics, Inc. showed an increase of +3.7% in Total Revenue compared to the prior fiscal year.
- Over the 2019–2025 period, Cyclerion Therapeutics, Inc.’s total revenue has declined by 54.0% (from $4.51 million to $2.07 million).
- The most recent figure is from Cyclerion Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: